38.12
Apogee Therapeutics Inc 주식(APGE)의 최신 뉴스
Apogee Therapeutics, Inc. (APGE) Soars on Promising Phase 2 Results for Atopic Dermatitis Drug - Yahoo Finance
11 Best Future Stocks to Buy Now - Insider Monkey
Published on: 2025-07-30 23:15:33 - metal.it
Apogee Therapeutics Shares Positive Interim Phase 1b Results for APG808 in Asthma - MSN
Multi Factor Analysis Ranks Apogee Therapeutics Inc. as Strong BuyIntraday Trend Analysis for Fast Gains Released - metal.it
Order Book Volume Tilts Bullish on Apogee Therapeutics Inc.Trade Ready Stock Watch for Short Term Published - metal.it
Should I hold or sell Apogee Therapeutics Inc. stock in 2025Triple-digit growth rates - jammulinksnews.com
Is Apogee Therapeutics Inc. stock overvalued or undervaluedFind the best stocks for sustainable growth - jammulinksnews.com
What makes Apogee Therapeutics Inc. stock price move sharplySolid Return Trade Selections - Newser
Intrinsic Value of Apogee Therapeutics Inc. Stock: Is It Undervalued or OvervaluedFree Elite Traders Group - Newser
What analysts say about Apogee Therapeutics Inc. stockOver 200% growth - PrintWeekIndia
What drives Apogee Therapeutics Inc. stock priceDynamic growth stocks - Autocar Professional
Apogee Therapeutics Inc. Stock Analysis and ForecastBreakthrough capital growth - Autocar Professional
What makes Apogee Therapeutics Inc. stock attractive to long term investorsDynamic growth stocks - jammulinksnews.com
Is Apogee Therapeutics Inc. a good long term investmentOutstanding capital returns - jammulinksnews.com
InvestingPro Fair Value model captures 43% downside in Apogee Therapeutics By Investing.com - Investing.com Canada
Teacher Retirement System of Texas Sells 629 Shares of Apogee Therapeutics Inc. (NASDAQ:APGE) - Defense World
BTIG Raises PT on Apogee Therapeutics (APGE) to $115 From $100, Keeps a Buy Rating - MSN
Will Apogee Therapeutics Inc. stock benefit from interest rate changesTop Gaining Low Risk Assets - Newser
12 Oversold NASDAQ Stocks to Buy Now - Insider Monkey
Apogee Therapeutics (APGE) Falls 17%, Positive Trial Results Fail to Impress Investors - MSN
Why Apogee Therapeutics Inc. stock attracts strong analyst attentionLow Risk Stock Strategies - Newser
How Apogee Therapeutics Inc. stock performs during market volatilityStable Growth Stock Picks - Newser
Canaccord Genuity Reiterated a Buy Rating on Apogee Therapeutics (APGE) - Insider Monkey
Analysts Set Apogee Therapeutics Inc. (NASDAQ:APGE) Price Target at $99.00 - Defense World
Rx Rundown: Merck, Gilead Sciences, Apogee Therapeutics and more - Medical Marketing and Media
Stifel reiterates Buy rating on Apogee Therapeutics stock amid positive AD data - Investing.com Nigeria
자본화:
|
볼륨(24시간):